NEW YORK (GenomeWeb News) – Saladax Biomedical said this week that it plans to open a CLIA lab at its headquarters in Bethlehem, Pa. The firm has applied for approval from both the State of Pennsylvania and the federal government and is targeting a launch next year.

Saladax offers MyCare tests for individualized dose management of three cancer drugs: 5-fluorouracil, paclitaxel, and docetaxel. It has another 10 MyCare tests in development, it said, and plans to offer the tests through the CLIA lab.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: locus linked to non-syndromic hearing loss, phylogenetic relationships of Klebsiella pneumoniae isolates, and more.

In a column at Nature, researcher Fyodor Kondrashov worries about the influence of politics on Russian science.

The term 'epigenetics' is being used by quacks to give them a veneer of science, writes Adam Rutherford at the Observer.

The NIH has issued a preliminary guidance for newborn dried blood spot research.